Poitiers University Hospital
Poitiers, France
NCT Number: NCT07228676
High-flow nasal oxygen (HFNO) is recommended as first-line treatment to prevent intubation in acute hypoxemic respiratory failure and to prevent reintubation after extubation. Accumulating data suggest that strong inspiratory efforts and their persistence are associated with HFNO failure. However, tools to monitor continuously and noninvasively inspiratory efforts are lacking. The investigators have developed an algorithm estimating noninvasively inspiratory efforts under HFNO. This pilot study aims at testing the feasibility of estimating inspiratory efforts in patients treated with HNFO.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Poitiers, France
High-flow nasal oxygen (HFNO) is recommended as first-line treatment to prevent intubation in acute hypoxemic respiratory failure and to prevent reintubation after extubation (alone in patients at low-risk of extubation failure, alternating with noninvasive ventilation in patients at high-risk of extubation failure). It consists in delivering high flow of heated and humidified gas enriched with oxygen through nasal cannulas. However, HFNO failure occurs in 30 to 50% of cases in acute hypoxemic respiratory failure and 10 to 20% of cases after extubation.
Accumulating data suggest that strong inspiratory efforts and their persistence are associated with HFNO failure. However, the monitoring of inspiratory efforts is challenging, especially in patients breathing spontaneously through the nose under HFNO. On a bench study, the investigators have developed an algorithm estimating noninvasively inspiratory efforts under HFNO based on the analysis of tracings of pressure and flow delivered by the HFNO device using an extracorporeal sensor. The coefficient of determination of the algorithm was high (R2=0.92). This pilot study aims at testing the feasibility of estimating inspiratory efforts in patients treated with HNFO.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
As soon as possible after inclusion and 2 hours later, tracings of pressure and flow delivered by the HFNO device will be collected using a noninvasive extracorporeal sensor placed between the nasal cannulas and the HFNO device, as well as vital signs and dyspnea. At each visit, tracings will be collected for 10 minutes using the HFNO flow set by the clinician and for 10 minutes using an HFNO flow of 30 L/min allowing the patient breathing mouth closed. During the recordings, patients will be monitored closely at the bedside by the investigator. Estimated inspiratory efforts under HFNO will be calculated a posteriori. HFNO failure (intubation or reintubation) will be assessed at day 7 of inclusion. Vital status will be assessed at day 28 of inclusion.
Time frame: Day 1
Inspiratory efforts will be calculated a posteriori using the algorithm developed on the bench, based on the pressure and flow signals delivered by the HFNO device collected during the first recording.
Time frame: Day 7
Inspiratory efforts estimated under HFNO in patients breathing through the nose at a flow rate of 30 L/min will be calculated a posteriori using the algorithm developed on the bench based on the pressure and flow signals delivered by the HFNO device collected during the first recording.
HFNO failure is defined as intubation or reintubation or death at day 7 after inclusion.
Time frame: Day 28
Inspiratory efforts estimated under HFNO in patients breathing through the nose at a flow rate of 30 L/min will be calculated a posteriori using the algorithm developed on the bench, based on the pressure and flow signals delivered by the HFNO device collected during the first recording.
Time frame: Day 7
The change in inspiratory efforts is defined as the decrease in estimated inspiratory efforts under HFNO in patients breathing through the nose at a flow rate of 30 L/min calculated a posteriori using the algorithm developed on the bench based on the pressure and flow signals delivered by the HFNO device between the first and second recording.
HFNO failure is defined as intubation or reintubation or death at day 7 after inclusion.
Time frame: Day 28
The change in inspiratory efforts is defined as the decrease in estimated inspiratory efforts under HFNO in patients breathing through the nose at a flow rate of 30 L/min calculated a posteriori using the algorithm developed on the bench based on the pressure and flow signals delivered by the HFNO device between the first and second recording.
Time frame: Day 1
Inspiratory effort estimated under HFNO in patients breathing through the nose at a flow rate of 30 L/min at each recording, and dyspnea score.
Dyspnea is defined as a value ≥ 4/10 on a numerical rating scale.
Poitiers University Hospital
Other
INSPIRatory Efforts Estimation Under High-flow Nasal Oxygen: a Pilot Study
Acronym: INSPIRE-Pilot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07369232
Antioxidant, Cerebral Autoregulation
Anderlecht, Brussels Capital, Belgium
View Trial DetailsNCT06398262
Measurement, Nasal Alar Collapse, Bilateral
Stockholm, Sweden
View Trial DetailsNCT05780671
Brain Diseases, Central Nervous System Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05746949
End-Tidal Carbon Dioxide, Oxygen
Istanbul, Fatih, Turkey (Türkiye)
View Trial Details